Radio surgery versus 80% phenol for toe nail matrix ablation: a randomised comparison study

ISRCTN ISRCTN32883274
DOI https://doi.org/10.1186/ISRCTN32883274
Secondary identifying numbers N0620171683
Submission date
29/09/2006
Registration date
29/09/2006
Last edited
19/08/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Ian Robinson
Scientific

Podiatry
Dean Clarke House
Southernhay East
Exeter
EX1 1PQ
United Kingdom

Study information

Study designSingle-centre blinded randomised comparative trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleRadio surgery versus 80% phenol for toe nail matrix ablation: a randomised comparison study
Study objectivesDoes the wound heal faster when 80% phenol is used to destroy the nail-producing cells or is healing faster when radio surgery is used to destroy the nail-producing cells?
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedSurgery: Toenail matrix ablation
Intervention60 participants (patients who have been referred for nail surgery) will be allocated an ID number. 30 randomised to 80% phenol and 30 will receive radio surgery technique for nail matrix ablation using a random number code.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Phenol
Primary outcome measureHealing time of the wound (to the nearest week). Pain experienced at each return visit following surgery measured using a visual scale, post-operative infection incidence measured by clinical signs and symptoms, nail regrowth incidence measured by clinical signs and symptoms, time to nail regrowth following surgery.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/09/2005
Completion date06/10/2007

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit80 Years
SexBoth
Target number of participants2 groups of 30
Key inclusion criteria1. Subjects will be males and females
2. Aged 18-80 years
3. They will be individuals referred to the podiatry department at the Royal Devon and Exeter Hospital (Heavitree) for nail surgery under local anaesthesia
4. They will present with a condition indicating the need for nail surgery including the following conditions:
4.1 Ingrowing toenail
4.2 Involuted nail
4.3 Fungal infection of the nail
4.4 Thickening of the nail
4.5 Severe nail hypertrophy
5. Each subject must be able to attend for follow-up visits including a 6-month visit and be able to provide informed consent
6. Participants will be happy to have their toe photographed and will be happy to be contacted by telephone after 1 year
Key exclusion criteria1. Fitted with a pacemaker, artificial heart valve, artificial joints or any other type of implant because these are contra-indications to radiosurgery
2. Subungual exostosis because treatment other than nail surgery is required for this condition
3. Contraindication to anaesthesia or the procedure according to standard guidelines
4. Pregnancy or breastfeeding
5. Unable to give informed consent
6. Inadequate blood supply to the foot or toe
Date of first enrolment01/09/2005
Date of final enrolment06/10/2007

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Podiatry
Exeter
EX1 1PQ
United Kingdom

Sponsor information

Record Provided by the NHSTCT Register - 2006 Update - Department of Health
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

Exeter Primary Care Trust (UK), NHS R&D Support Funding

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan